|
시장보고서
상품코드
1786987
세계의 말초동맥질환 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 치료 유형별, 유통 채널별, 최종 사용자별, 지역별 예측(2025-2034년)Peripheral Artery Disease Market Size, Share, Trend, Industry Analysis Report By Treatment Type (Device, Drugs), By Distribution Channel, By End User, By Region - Market Forecast, 2025-2034, and By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 세계의 말초동맥질환(PAD) 시장 규모는 2034년까지 105억 3,000만 달러에 이를 것으로 예측됩니다. 이 보고서는 현재 시장 역학을 상세하게 통찰하고 미래 시장 성장에 대한 분석을 제공합니다.
말초동맥질환(PAD) 시장은 주로 하지에 영향을 미치는 말초 동맥의 죽상 경화성 폐색의 진단, 치료 및 관리에 중점을 둡니다. 이 질환은 혈류를 낮추고 통증, 조직 손상, 심한 경우 사지 절단을 유발합니다. 당뇨병, 고혈압, 흡연, 비만과 같은 위험 인자의 유병률 증가는 대상 인구를 확대하고 효과적인 PAD 치료에 대한 수요를 부추기고 있습니다. 혈관 영상과 조기 진단 도구의 진보에 의해 발견률이 향상되고 있는 한편, 저침습 치료로의 시프트는 기존 수술보다 혈관내 치료가 선호되는 경향이 있습니다. 약물 용출 스텐트, 풍선 혈관 성형술, 아테렉토미 시스템과 같은 기술 진보는 환자 결과와 절차 효율성을 향상시킵니다. 시장 개척은 또한 병용 요법과 질병의 중증도와 환자의 병존 질환에 맞는 맞춤형 치료 접근법의 개발에 의해 지원됩니다.
디지털 건강 플랫폼을 혈관 치료에 통합하면 원격 모니터링, 치료 어드히어런스 및 데이터 중심의 개입이 가능합니다. 연구 및 임상시험에 대한 강력한 투자는 특히 항 재협착 장치와 생체 흡수성 임플란트의 기술 혁신을 계속 형성하고 있습니다. 의료 서비스 제공업체, 의료 기술 기업 및 연구 기관의 전략적 제휴는 첨단 PAD 솔루션의 상업화를 촉진하고 있습니다. 또한 인지도 향상 캠페인과 스크리닝 노력이 조기 개입을 촉진하여 대응 가능한 시장을 확대하고 있습니다. 가치관에 기초한 치료와 환자 중심의 치료모델이 중시되게 됨으로써 비용효과가 높고 결과에 중점을 둔 PAD 치료의 중요성이 높아지고 있습니다. 시장 경쟁과 혁신은 여전히 지속되고 있으며, 말초 혈관 질환 관리에서 미충족 요구에 대응하기 위해 최선을 다하는 이해 관계자에게 큰 비즈니스 기회가 생길 것입니다.
말초동맥질환 시장 보고서 하이라이트
치료 유형별로는 스텐트, 혈관성형술용 풍선, 저침습 수술용 죽종 절제 기기의 채용 확대가 디바이스 분야의 왕성한 수요에 기여하고 있기 때문에 2024년의 매출 점유율은 디바이스 분야가 최대 62%를 차지했습니다.
유통 채널별로는 혈관성형술이나 바이패스 수술 등의 복잡한 PAD 인터벤션을 위한 환자 유입이 많아 병원 약국의 우위성에 기여하고 있기 때문에 병원 약국 부문이 2024년 최대의 수익 점유율을 차지했습니다.
아시아태평양은 2025년부터 2034년까지 크게 성장할 것으로 예측됩니다.
북미의 말초동맥질환 시장은 당뇨병, 비만, 흡연 등 심혈관 위험 인자의 높은 유병률로 2024년 최대 판매 점유율을 차지했습니다.
세계 주요 기업은 Amedisys, Inc., B. Braun SE, Baxter, BD, CareCentrix, Inc., Coram LLC., Fresenius Kabi AG, ICU Medical, Inc., JMS Co. Ltd., Moog Inc., Option Care Health, Inc., PharMerica Corporation, and Terumo Corporation 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 말초동맥질환 시장 인사이트
- 시장 현황
- 말초동맥질환 시장 역학
- 성장 촉진요인과 기회
- 당뇨병과 고혈압의 유병률 상승
- 세계 인구의 고령화
- 억제요인과 과제
- 치료비가 고액.
- 성장 촉진요인과 기회
- PESTEL 분석
- 말초동맥질환 시장 동향
- 밸류체인 분석
제5장 세계의 말초동맥질환 시장 : 치료 유형별
- 주요 조사 결과
- 소개
- 디바이스
- 약제 유형
제6장 세계의 말초동맥질환 시장 : 유통 채널별
- 주요 조사 결과
- 소개
- 병원 약국
- 소매 약국
- 기타
제7장 세계의 말초동맥질환 시장 : 최종 사용자별
- 주요 조사 결과
- 소개
- 병원
- 전문 클리닉
- 외래수술센터(ASC)
제8장 세계의 말초동맥질환 시장 : 지역별
- 주요 조사 결과
- 소개
- 말초동맥질환 시장 평가 : 지역별, 2020-2034년
- 북미
- 북미 : 치료 유형별, 2020-2034년
- 북미 : 유통 채널별, 2020-2034년
- 북미 : 최종 사용자별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 치료 유형별, 2020-2034년
- 유럽 : 유통 채널별, 2020-2034년
- 유럽 : 최종 사용자별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 치료 유형별, 2020-2034년
- 아시아태평양 : 유통 채널별, 2020-2034년
- 아시아태평양 : 최종 사용자별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 치료 유형별, 2020-2034년
- 중동 및 아프리카 : 유통 채널별, 2020-2034년
- 중동 및 아프리카 : 최종 사용자별, 2020-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 치료 유형별, 2020-2034년
- 라틴아메리카 : 유통 채널별, 2020-2034년
- 라틴아메리카 : 최종 사용자별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 프로파일
- Abbott
- AngioDynamics
- B. Braun SE
- Bayer AG
- BD
- Biotronik
- Boston Scientific Corporation
- Cardinal Health
- Endologix LLC
- iVascular
- Johnson & Johnson
- Koninklijke Philips NV
- Medtronic
- Terumo Corporation
The peripheral artery disease (PAD) market size is expected to reach USD 10.53 billion by 2034, according to a new study by Polaris Market Research. The report "Peripheral Artery Disease Market Size, Share, Trend, Industry Analysis Report By Treatment Type (Device, Drugs), By Distribution Channel, By End User, By Region - Market Forecast, 2025-2034," gives a detailed insight into current market dynamics and provides analysis on future market growth.
The peripheral artery disease (PAD) market focuses on the diagnosis, treatment, and management of atherosclerotic blockages in the peripheral arteries, primarily affecting the lower extremities. This condition leads to reduced blood flow, causing pain, tissue damage, and in severe cases, limb amputation. The increasing prevalence of risk factors such as diabetes, hypertension, smoking, and obesity is expanding the target population and fueling demand for effective PAD therapies. Advancements in vascular imaging and early diagnostic tools are improving detection rates, while the shift toward minimally invasive procedures is driving preference for endovascular treatments over traditional surgery. Technological progress in drug-eluting stents, balloon angioplasty, and atherectomy systems is enhancing patient outcomes and procedural efficiency. Market growth is further supported by the development of combination therapies and personalized treatment approaches tailored to disease severity and patient comorbidities.
The integration of digital health platforms into vascular care is enabling remote monitoring, treatment adherence, and data-driven interventions. Strong investments in research and clinical trials continue to shape innovation, particularly in anti-restenosis devices and bioresorbable implants. Strategic collaborations among healthcare providers, medtech firms, and research institutions are fostering the commercialization of advanced PAD solutions. In addition, increasing awareness campaigns and screening initiatives are encouraging earlier intervention, thus expanding the addressable market. Growing emphasis on value-based care and patient-centric treatment models is reinforcing the importance of cost-effective and outcome-driven PAD therapies. The market remains competitive and innovation-driven, presenting substantial opportunities for stakeholders committed to addressing unmet needs in peripheral vascular disease management.
Peripheral Artery Disease Market Report Highlights
By treatment type, the device segment accounted for ~62% of the revenue share in 2024, due to the wider adoption of stents, angioplasty balloons, and atherectomy devices for minimally invasive procedures is contributing to strong demand in the device segment.
Based on distribution channel, the hospital pharmacy segment accounted for the largest revenue share in 2024 due to the high patient inflow for complex PAD interventions, such as angioplasty or bypass surgeries, contributes to the dominance of hospital pharmacies.
Asia Pacific is expected to grow significantly from 2025 to 2034 due to rapidly expanding healthcare systems, rising disposable income, and growing health awareness are contributing to improved PAD screening and diagnosis rates.
The North America peripheral artery disease market accounted for the largest revenue share in 2024 due to the high prevalence of cardiovascular risk factors, such as diabetes, obesity, and smoking, has increased the burden of peripheral artery disease across the region.
A few global key players include Amedisys, Inc.; B. Braun SE; Baxter; BD; CareCentrix, Inc.; Coram LLC.; Fresenius Kabi AG; ICU Medical, Inc.; JMS Co. Ltd.; Moog Inc.; Option Care Health, Inc.; PharMerica Corporation; and Terumo Corporation.
Polaris Market Research has segmented the peripheral artery disease market report on the basis of treatment type, distribution channel, end user, and region:
By Treatment Type Outlook (Revenue, USD Billion, 2020-2034)
Device
Balloon Catheters
Plaque Modification Devices
Stents
Atherectomy Devices
Guidewires and Sheaths
Other Devices
Drug Type
Lipid-lowering Drugs
Antiplatelet Drugs
Thrombolytic Agents
Triple-H Therapy
Other Drugs
By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)
Hospital Pharmacy
Retail Pharmacy
Others
By End User Outlook (Revenue, USD Billion, 2020-2034)
Hospital
Specialty Clinics
Ambulatory Surgical Centers
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Vietnam
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Peripheral Artery Disease Market Insights
- 4.1. Peripheral Artery Disease Market - Market Snapshot
- 4.2. Peripheral Artery Disease Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Diabetes and Hypertension
- 4.2.1.2. Aging Global Population
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High treatment costs.
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Peripheral Artery Disease Market Trends
- 4.6. Value Chain Analysis
5. Global Peripheral Artery Disease Market, by Treatment Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 5.3. Device
- 5.3.1. Global Peripheral Artery Disease Market, by Device, by Region, 2020-2034 (USD Billion)
- 5.3.2. Balloon Catheters
- 5.3.2.1. Global Peripheral Artery Disease Market, by Balloon Catheters, 2020-2034 (USD Billion)
- 5.3.3. Plaque Modification Devices
- 5.3.3.1. Global Peripheral Artery Disease Market, by Plaque Modification Devices, by Region, 2020-2034 (USD Billion)
- 5.3.4. Stents
- 5.3.4.1. Global Peripheral Artery Disease Market, by Stents, 2020-2034 (USD Billion)
- 5.3.5. Atherectomy Devices
- 5.3.5.1. Global Peripheral Artery Disease Market, by Atherectomy Devices, by Region, 2020-2034 (USD Billion)
- 5.3.6. Guidewires and Sheaths
- 5.3.6.1. Global Peripheral Artery Disease Market, by Guidewires and Sheaths, 2020-2034 (USD Billion)
- 5.3.7. Other Devices
- 5.3.7.1. Global Peripheral Artery Disease Market, by Other Devices, by Region, 2020-2034 (USD Billion)
- 5.4. Drug Type
- 5.4.1. Global Peripheral Artery Disease Market, by Drug Type, by Region, 2020-2034 (USD Billion)
- 5.4.2. Lipid-lowering Drugs
- 5.4.2.1. Global Peripheral Artery Disease Market, by Lipid-lowering Drugs, 2020-2034 (USD Billion)
- 5.4.3. Antiplatelet Drugs
- 5.4.3.1. Global Peripheral Artery Disease Market, by Antiplatelet Drugs, by Region, 2020-2034 (USD Billion)
- 5.4.4. Thrombolytic Agents
- 5.4.4.1. Global Peripheral Artery Disease Market, by Thrombolytic Agents, 2020-2034 (USD Billion)
- 5.4.5. Triple-H Therapy
- 5.4.5.1. Global Peripheral Artery Disease Market, by Triple-H Therapy, by Region, 2020-2034 (USD Billion)
- 5.4.6. Other Drugs
- 5.4.6.1. Global Peripheral Artery Disease Market, by Other Drugs, 2020-2034 (USD Billion)
6. Global Peripheral Artery Disease Market, by Distribution Channel
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 6.3. Hospital Pharmacy
- 6.3.1. Global Peripheral Artery Disease Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
- 6.4. Retail Pharmacy
- 6.4.1. Global Peripheral Artery Disease Market, by Retail Pharmacy, by Region, 2020-2034 (USD Billion)
- 6.5. Others
- 6.5.1. Global Peripheral Artery Disease Market, by Others, by Region, 2020-2034 (USD Billion)
7. Global Peripheral Artery Disease Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 7.3. Hospital
- 7.3.1. Global Peripheral Artery Disease Market, by Hospital, by Region, 2020-2034 (USD Billion)
- 7.4. Specialty Clinics
- 7.4.1. Global Peripheral Artery Disease Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
- 7.5. Ambulatory Surgical Centers
- 7.5.1. Global Peripheral Artery Disease Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)
8. Global Peripheral Artery Disease Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Peripheral Artery Disease Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Peripheral Artery Disease Market - North America
- 8.3.1. North America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.3. North America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. Peripheral Artery Disease Market - U.S.
- 8.3.4.1. U.S.: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. Peripheral Artery Disease Market - Canada
- 8.3.5.1. Canada: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4. Peripheral Artery Disease Market - Europe
- 8.4.1. Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.3. Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. Peripheral Artery Disease Market - UK
- 8.4.4.1. UK: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. Peripheral Artery Disease Market - France
- 8.4.5.1. France: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.4.5.2. France: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.5.3. France: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. Peripheral Artery Disease Market - Germany
- 8.4.6.1. Germany: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. Peripheral Artery Disease Market - Italy
- 8.4.7.1. Italy: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. Peripheral Artery Disease Market - Spain
- 8.4.8.1. Spain: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. Peripheral Artery Disease Market - Netherlands
- 8.4.9.1. Netherlands: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. Peripheral Artery Disease Market - Russia
- 8.4.10.1. Russia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. Peripheral Artery Disease Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5. Peripheral Artery Disease Market - Asia Pacific
- 8.5.1. Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. Peripheral Artery Disease Market - China
- 8.5.4.1. China: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.5.4.2. China: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.4.3. China: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. Peripheral Artery Disease Market - India
- 8.5.5.1. India: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.5.5.2. India: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.5.3. India: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. Peripheral Artery Disease Market - Malaysia
- 8.5.6.1. Malaysia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. Peripheral Artery Disease Market - Japan
- 8.5.7.1. Japan: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. Peripheral Artery Disease Market - Indonesia
- 8.5.8.1. Indonesia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. Peripheral Artery Disease Market - South Korea
- 8.5.9.1. South Korea: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. Peripheral Artery Disease Market - Australia
- 8.5.10.1. Australia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. Peripheral Artery Disease Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6. Peripheral Artery Disease Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. Peripheral Artery Disease Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. Peripheral Artery Disease Market - UAE
- 8.6.5.1. UAE: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. Peripheral Artery Disease Market - Israel
- 8.6.6.1. Israel: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. Peripheral Artery Disease Market - South Africa
- 8.6.7.1. South Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. Peripheral Artery Disease Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.7. Peripheral Artery Disease Market - Latin America
- 8.7.1. Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. Peripheral Artery Disease Market - Mexico
- 8.7.4.1. Mexico: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. Peripheral Artery Disease Market - Brazil
- 8.7.5.1. Brazil: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. Peripheral Artery Disease Market - Argentina
- 8.7.6.1. Argentina: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. Peripheral Artery Disease Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. AngioDynamics
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. B. Braun SE
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Bayer AG
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. BD
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Biotronik
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Boston Scientific Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Cardinal Health
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Endologix LLC
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. iVascular
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Johnson & Johnson
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Koninklijke Philips N.V.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Medtronic
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Terumo Corporation
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
